Table 3. Comparison of EGFR/KRAS/ALK mutations between 30 thoracic biopsy specimens detected by ARMS and matched pleural effusion specimens detected by NGS.
Pleural effusion specimen (NGS) | Thoracic biopsy specimen (ARMS) | ||
---|---|---|---|
+ | − | Total | |
+ | 24 | 2 | 26 |
− | 2 | 2 | 4 |
Total | 26 | 4 | 30 |
+, EGFR/KRAS/ALK positive mutation; −, EGFR/KRAS/ALK negative mutation. NGS, next-generation sequencing.